Urinary tract biomaterials

被引:79
作者
Beiko, DT
Knudsen, BE
Watterson, JD
Cadieux, PA
Reid, G
Denstedt, JD
机构
[1] Queens Univ, Dept Urol, Kingston, ON, Canada
[2] Univ Western Ontario, Dept Microbiol, London, ON, Canada
[3] Univ Western Ontario, Dept Immunol, London, ON, Canada
[4] Univ Ottawa, Div Urol, Ottawa, ON, Canada
关键词
urinary tract; biocompatible materials; urinary diversion; prostheses and implants;
D O I
10.1097/01.ju.0000125001.56045.6c
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose: As a result of endourological advances, biomaterials have become increasingly used within the urinary tract. This review article provides an update on the current status of urinary tract biomaterials, discussing issues of biocompatibility, biomaterials available for use, clinical applications and biomaterial related complications. Perspectives on future materials for use in the urinary tract are also provided. Materials and Methods: We performed a comprehensive search of the peer reviewed literature on all aspects of biomaterials in the urinary tract using PubMed and MEDLINE. All pertinent articles were reviewed in detail. Results: Any potential biomaterial must undergo rigorous physical and biocompatibility testing prior to its commercialization and use in humans. There are currently many different bulk materials and coatings available for the manufacturing of biomaterials, although the ideal material has yet to be discovered. For use in the urinary tract, biomaterials may be formed into devices, including ureteral and urethral stents, urethral catheters and percutaneous nephrostomy tubes. Despite significant advances in basic science research involving biocompatibility issues and biofilm formation, infection and encrustation remain associated with the use of biomaterials in the urinary tract and, therefore, limit their long-term indwelling time. Conclusions: Prosthetic devices formed from biomaterials will continue to be an essential tool in the practicing urologist's armamentarium. Ongoing research is essential to optimize biocompatibility and decrease biomaterial related complications such as infection and encrustation within the urinary tract. Future advances include biodegradables, novel coatings and tissue engineering.
引用
收藏
页码:2438 / 2444
页数:7
相关论文
共 77 条
[1]
Adams F., 1846, 7 BOOKS PAULUS AEGIN
[2]
Metal mesh stents for ureteral obstruction caused by hormone-resistant carcinoma of prostate [J].
Ahmed, M ;
Bishop, MC ;
Bates, CP ;
Manhire, AR .
JOURNAL OF ENDOUROLOGY, 1999, 13 (03) :221-224
[3]
Tissue engineered stents created from chondrocytes [J].
Amiel, GE ;
Yoo, JJ ;
Kim, BS ;
Atala, A .
JOURNAL OF UROLOGY, 2001, 165 (06) :2091-2095
[4]
Liposome-coated metal stents:: An in vitro evaluation of controlled-release modality in the ureter [J].
Antimisiaris, SG ;
Siablis, D ;
Liatsikos, E ;
Kalogeropoulou, C ;
Tsota, I ;
Tsotas, V ;
Karnabatidis, D ;
Fatouros, DG ;
Barbalias, GA .
JOURNAL OF ENDOUROLOGY, 2000, 14 (09) :743-747
[5]
Evaluation of a temporary dissolvable ureteral drainage stent in a swine model [J].
Auge, BK ;
Ferraro, RF ;
Madenjian, AR ;
Preminger, GM .
JOURNAL OF UROLOGY, 2002, 168 (02) :808-812
[6]
Metal stents: A new treatment of malignant ureteral obstruction [J].
Barbalias, GA ;
Siablis, D ;
Liatsikos, EN ;
Karnabatidis, D ;
Yarmenitis, S ;
Bouropoulos, K ;
Dimopoulos, J .
JOURNAL OF UROLOGY, 1997, 158 (01) :54-58
[7]
Externally coated ureteral metallic stents: An unfavorable clinical experience [J].
Barbalias, GA ;
Liatsikos, EN ;
Kalogeropoulou, C ;
Karnabatidis, D ;
Zabakis, P ;
Athanasopoulos, A ;
Perimenis, P ;
Siablis, D .
EUROPEAN UROLOGY, 2002, 42 (03) :276-280
[8]
Bitschay J, 1956, HIST UROLOGY EGYPT, P56
[9]
A BRIEF-HISTORY OF URETHRAL CATHETERIZATION [J].
BLOOM, DA ;
MCGUIRE, EJ ;
LAPIDES, J .
JOURNAL OF UROLOGY, 1994, 151 (02) :317-325
[10]
BORGOGNONI T, 1993, SURG THEODORIC, V7, P89